ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma

作者：Kimura Yasushi; Kasamatsu Atsushi^*; Nakashima Dai; Yamatoji Masanobu; Minakawa Yasuyuki; Koike Kazuyuki; Fushimi Kazuaki; Higo Morihiro; Endo Sakamoto Yosuke; Shiiba Masashi; Tanzawa Hideki; Uzawa Katsuhiro^*

来源：Journal of Cancer, 2016, 7(6): 702-710.

DOI：10.7150/jca.14208

• ARNT2
• oral squamous cell carcinoma
• cellular proliferation
• VHL
• HIF1-alpha
• GLUT-1

Aryl hydrocarbon receptor nuclear translocator (ARNT) 2 is a transcriptional factor related to adaptive responses against cellular stress from a xenobiotic substance. Recent evidence indicates ARNT is involved in carcinogenesis and cancer progression; however, little is known about the relevance of ARNT2 in the behavior of oral squamous cell carcinoma (OSCC). In the current study, we evaluated the ARNT2 mRNA and protein expression levels in OSCC in vitro and in vivo and the clinical relationship between ARNT2 expression levels in primary OSCCs and their clinicopathologic status by quantitative reverse transcriptase-polymerase chain reaction, immunoblotting, and immunohistochemistry. Using ARNT2 overexpression models, we performed functional analyses to investigate the critical roles of ARNT2 in OSCC. ARNT2 mRNA and protein were down-regulated significantly (P < 0.05 for both comparisons) in nine OSCC-derived cells and primary OSCC (n=100 patients) compared with normal counterparts. In addition to the data from exogenous experiments that ARNT2-overexpressed cells showed decreased cellular proliferation, ARNT2-positive OSCC cases were correlated significantly (P < 0.05) with tumoral size. Since von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase, a negative regulator of hypoxia-inducible factor (HIF1)-alpha, is a downstream molecule of ARNT2, we speculated that HIF1-alpha and its downstream molecules would have key functions in cellular growth. Consistent with our hypothesis, overexpressed ARNT2 cells showed down-regulation of HIF1-alpha, which causes hypofunctioning of glucose transporter 1, leading to decreased cellular growth. Our results proposed for the first time that the ARNT2 level is an indicator of cellular proliferation in OSCCs. Therefore, ARNT2 may be a potential therapeutic target against progression of OSCCs.

• 出版日期2016